Description
Hepatitis B and hepatitis D are important causes of chronic liver disease, yet many individuals remain undiagnosed until advanced disease develops. This program aims to support clinicians in implementing the recent updates to the CASL/AMMI Canada guidelines on the screening, vaccination, and treatment of hepatitis B (HBV) and hepatitis D (HDV). Using a patient case, this program will highlight what has changed and how to incorporate these changes into practice.
Course Features:
– 1 video lecture,
– 4 interactive quizzes,
– 1 downloadable resource.
Content Covered:
Module: Advancing HBV and HDV Screening: Applying New Guidelines to Clinical Practice.
This program has received an unrestricted educational grant or in-kind support from Gilead.